-
1 Comment
Bio-Gene Technology Limited is currently in a long term uptrend where the price is trading 15.4% above its 200 day moving average.
From a valuation standpoint, the stock is 91.1% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 23.0.
Bio-Gene Technology Limited's total revenue sank by 82.3% to $89K since the same quarter in the previous year.
Its net income has dropped by 25.3% to $-1M since the same quarter in the previous year.
Finally, its free cash flow grew by 42.6% to $-245K since the same quarter in the previous year.
Based on the above factors, Bio-Gene Technology Limited gets an overall score of 3/5.
| Sector | Healthcare |
|---|---|
| CurrencyCode | AUD |
| ISIN | AU000000BGT8 |
| Exchange | AU |
| Industry | Biotechnology |
| PE Ratio | None |
|---|---|
| Target Price | 0.373 |
| Market Cap | 5M |
| Beta | 0.38 |
| Dividend Yield | None |
Bio-Gene Technology Limited, an agtech development company, engages in the development and commercialization of naturally derived insecticide products in Australia and internationally. Its products include Flavocide, a synthetically produced nature-identical compound; Qcide, a natural plant-derived oil with high levels of tasmanone. The company has a research collaboration agreement with James Cook University to support research and field operations relating to processing and distillation of oil from biomass; AgriFor Scientific, a chemistry product; cesar for assessing the insecticidal activity of molecules against a various insect species; CSIRO, a chemistry development process; Department of Agriculture and Fisheries, Queensland Government for assessing activity against grain storage pests; Eurofins; Grain Research Development Corporation; Pacific Discovery Services; Purdue University; Southern Cross University, a chemical analysis of natural products; University of Florida; and University of Technology. It serves animal health, crop protection, grain storage, public health, and consumer applications. The company was incorporated in 1995 and is based in Melbourne, Australia.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for BGT.AU using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
